SleepUp Is Becoming the Brazilian Insomniac's Sleep Clinic

The startup secured ANVISA approval as Brazil's first digital therapeutic for sleep disorders, aiming to reach patients through pharmacies and health plans.

About SleepUp

Published

For the estimated 73 million Brazilians grappling with a sleep disorder, the path to treatment is often a long one, marked by waiting lists for sleep clinics, the stigma of a mental health diagnosis, and the inconsistent availability of cognitive behavioral therapy [Exame]. SleepUp, a London-founded startup with operations in São Paulo, is betting that a regulated digital therapeutic, delivered via a smartphone app and a wearable EEG headband, can be the answer. It is a bet that has already cleared a significant regulatory hurdle, securing approval from ANVISA, Brazil's health authority, as the country's first digital therapeutic (DTx) for sleep disorders [Digital Therapeutics Alliance]. The company has raised a total of roughly $2 million in seed funding from investors including Criatec 4 and Poli Angels, building a bridge between clinical validation and scalable access in a large, underserved market [Pequenas Empresas Grandes Negócios, Jul 2025] [Crunchbase, Oct 2022].

The ANVISA Wedge

In the world of digital health, regulatory approval is not just a stamp of legitimacy, it is a commercial key. For SleepUp, ANVISA clearance transforms its offering from a wellness app into a prescribable medical device. This allows the company to pursue a B2B2C model, integrating its platform into the workflows of health insurance companies and retail pharmacy chains across Brazil [Perplexity Sonar]. The core product combines a mobile application offering personalized cognitive behavioral therapy for insomnia (CBT-I) with a wearable EEG headband for sleep monitoring. AI algorithms are used to tailor therapeutic content and track progress, creating a closed-loop system intended to replicate the guidance of a sleep specialist [Perplexity Sonar]. This regulatory-first approach provides a clear wedge into a fragmented healthcare system.

Building the Clinical Bridge

The team, led by co-founders Renata Redondo Bonaldi (CEO) and Paula Redondo (CTO), has focused on embedding the company within Brazil's medical and innovation ecosystem from the start. SleepUp is an alumnus of accelerators run by the Founder Institute, Samsung, and Hospital Albert Einstein, a prestigious medical institution in São Paulo [Perplexity Sonar]. Renata Redondo Bonaldi, who holds a PhD and a Global MBA, has actively represented the company in digital health forums, including appearances on industry podcasts discussing the integration of wearables and AI in sleep medicine [Health Podcast Network]. This focus on clinical and institutional credibility is a deliberate strategy to build trust with both prescribing physicians and paying enterprise partners.

The Path to Scale and Its Pressures

The ambition is clear, but the path from regulatory approval to widespread adoption is lined with executional challenges common to digital therapeutics. The company must now prove it can secure and service large contracts with health plans and pharmacy networks, a sales motion that requires deep relationships and evidence of cost savings or improved outcomes. While the company reported over 8,000 users shortly after its July 2020 launch, there is no public update on that figure or on specific enterprise customer names, making it difficult to gauge current commercial traction [Pequenas Empresas Grandes Negócios, Nov 2021]. Furthermore, the digital sleep health space, while nascent in Latin America, is crowded globally. SleepUp must demonstrate that its combination of ANVISA approval, localized content, and a hardware-plus-software bundle creates a defensible moat against both international DTx players and future local entrants.

The company's seed funding history, while supportive, indicates it is operating with capital efficiency typical of the early stage.

2021 Seed | Undisclosed |
2022 Seed | Undisclosed |
2025 Seed | Undisclosed |

Success in the next 12 to 18 months will likely be measured by a few concrete signals. These will be less about user counts and more about the depth of its integration into the Brazilian healthcare infrastructure.

  • Enterprise partnerships. Announcing a named contract with a major health insurer or pharmacy chain would be a powerful validation of its B2B2C model.
  • Clinical evidence. Publishing peer-reviewed data on patient outcomes within the Brazilian population would strengthen its value proposition to medical partners.
  • Follow-on funding. A Series A round would signal investor confidence in its commercial execution post-ANVISA approval and provide fuel for scaling its commercial team.

The Patient at the Center

Ultimately, SleepUp's thesis rests on a specific and significant patient population: individuals in Brazil suffering from chronic insomnia and other sleep disorders. The standard of care today for these patients is often inaccessible or inconsistent. Specialized sleep clinics are concentrated in urban centers, wait times can be prohibitive, and the gold-standard behavioral therapy, CBT-I, requires trained therapists who are in short supply. Treatment often defaults to pharmaceutical interventions, which can carry side effects and dependency risks. SleepUp is attempting to democratize access to a structured, non-pharmacological intervention, placing a guided, evidence-based program directly into a patient's daily routine. The company's progress will be a telling case study in whether digital therapeutics can truly bridge the gap between clinical validation and mass-market patient access in emerging healthcare systems.

Sources

  1. [Exame] Negócio dos sonhos: startup que trata a insônia ganha aporte de R$ 2 mi | https://exame.com/tecnologia/negocio-dos-sonhos-startup-que-trata-a-insonia-recebe-aporte-de-2-milhoes/
  2. [Digital Therapeutics Alliance] First DTx approved by ANVISA for sleep disorders in Brazil | https://dtxalliance.org/
  3. [Pequenas Empresas Grandes Negócios, Jul 2025] Seed round led by Criatec 4 | https://revistapegn.globo.com/
  4. [Crunchbase, Oct 2022] Seed Round - SleepUp - 2022-10-19 | https://www.crunchbase.com/funding_round/sleepup-seed--0e92085c
  5. [Perplexity Sonar] SleepUp company overview and business model |
  6. [Pequenas Empresas Grandes Negócios, Nov 2021] Esta startup quer melhorar a vida de quem sofre de insônia | https://revistapegn.globo.com/Startups/noticia/2021/11/esta-startup-quer-melhorar-vida-de-quem-sofre-de-insonia.html
  7. [Health Podcast Network] Sleep and Digital Health in Brazil (Renata Redondo Bonaldi) | https://healthpodcastnetwork.com/episodes/faces-of-digital-health/sleep-and-digital-health-in-brazil-renata-redondo-bonaldi/

Read on Startuply.vc